Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.2.2
Stockholders’ Equity (Tables)
3 Months Ended
Oct. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of summarizes restricted stock unit (“RSU”) activity
    Three months ended
October 31,
 
    2022     2021  
Stock options and performance stock units   $ 244       216  
Restricted stock units     186      
 
    $ 430       216  

 

Schedule of expense related to share-based payment arrangements
    Three months ended
October 31,
 
    2022     2021  
Selling, general and administrative   $ 408       212  
Cost of revenues     22       4  
    $ 430       216  

 

Schedule of stock option activity
     Options         Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value
(000s)
 
Outstanding at July 31, 2022     3,941,783     $ 3.00                             
Awarded     15,000     $ 2.42                  
Exercised    
                    $    
Cancelled or expired     (251,066 )   $ 2.94                  
Outstanding at end of period     3,705,717     $ 3.00        2.4 years       $
 
Exercisable at end of period     1,794,399     $          0.6 years       $    

 

Schedule of PSU’s granted and outstanding
Grant Date   Total Grant     Forfeitures     Outstanding     Fair Market
Value At
Grant Date
(000s)
 
10/19/2020     98,600       (40,300 )     58,300     $ 122  

 

Schedule of summarizes restricted stock unit (“RSU”) activity
    Number of 
RSUs 
outstanding
    Weighted
Average Fair
Value per
Unit at
Date of
Grant or
Vesting
    Weighted
Average
Remaining
Contractual
Term
  Aggregate
Intrinsic
Value (000s)
 
Outstanding at July 31, 2022     502,187     $ 2.95               
Granted    
                     
Vested    
     
 
             
Cancelled    
    $
 
             
Outstanding at end of period     502,187     $ 2.95     1.6 years   $ 1,075  
Expected to vest at end of period     502,187     $       1.6 years   $